{"id":"W4403285343","doi":"10.1016/j.clon.2024.10.008","title":"Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab","year":2024,"lang":"en","type":"article","venue":"Clinical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Medicine; Pembrolizumab; Lenvatinib; Tolerability; Internal medicine; Oncology; Carcinosarcoma; Endometrial cancer; Population; Cancer; Adverse effect; Carcinoma; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004115749,0.0003766953,0.001915797,0.0005990841,0.00004435626,0.00002331819,0.0001459324,0.0001661093,0.001088947],"category_scores_gemma":[0.0009109671,0.0001902406,0.0002202783,0.00233762,0.0002646574,0.0001389075,0.00005934584,0.000729857,0.00006586986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001145536,"about_ca_system_score_gemma":0.001513364,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006749255,"about_ca_topic_score_gemma":0.005377664,"domain_scores_codex":[0.9966792,0.0003120204,0.001189984,0.0007894424,0.0004865363,0.0005428146],"domain_scores_gemma":[0.994929,0.003958521,0.0002493902,0.0003275998,0.0001622874,0.0003731659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1009272,0.002276344,0.6549841,0.0001190727,0.0009912702,0.000765325,0.00004440693,0.00001114256,0.000001085761,0.00007740934,0.0002355893,0.2395671],"study_design_scores_gemma":[0.1270382,0.03639619,0.8172227,0.0005110194,0.001272084,0.000009647382,0.00003531944,0.00004765374,0.00001223121,0.00004341768,0.01710556,0.0003060371],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902688,0.0005397344,0.00001058254,0.001182256,0.001257219,0.001774357,0.0001190268,0.0001413865,0.004706634],"genre_scores_gemma":[0.9908419,0.0008343952,0.001534684,0.0006120621,0.0004046399,0.0005444029,0.0001505434,0.00006971837,0.00500768],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2392611,"threshold_uncertainty_score":0.9998242,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.106635617466079,"score_gpt":0.4543742902599759,"score_spread":0.3477386727938969,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}